Recent reports have indicated that miR-103 inhibits tumor cell proliferation in PCa by targeting programmed cell death protein 10 (PDCD10), while miR-103a-3p is also low in bladder cancer (Fu et al., 2016; Zhong et al., 2016). Here, PDCD10 is linked to urinary bladder carcinoma.